Alirocumab (anti-PCSK9), CAS [[1245916-14-6]]

Produktübersicht

• Artikelname: Alirocumab (anti-PCSK9), CAS [[1245916-14-6]]
• Artikelnummer: MCE-HY-P9928A
• Hersteller Artikelnummer: HY-P9928A
• Alternativnummer: MCE-HY-P9928A-2MG,MCE-HY-P9928A-5MG,MCE-HY-P9928A-1MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: REGN 727(anti-PCSK9), SAR 236553(anti-PCSK9)

Produktbeschreibung

Alirocumab (anti-PCSK9) is an anti-PCSK9 human monoclonal antibody. Alirocumab (anti-PCSK9) inhibits PCSK9. Alirocumab (anti-PCSK9) reduces NLRP3 inflammasome, regulates Nrf2/HO-1, HMGB1/NF-kappaB and Fractalkine/CX3CR1. Alirocumab (anti-PCSK9) increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab (anti-PCSK9) improves atherosclerosis and inflammation[1][2][3][4][5][6][7][8][9][10][11].

Produkteigenschaften

• Molekulargewicht: (146.24 kDa)
• Reinheit: 98.24
• CAS Nummer: [1245916-14-6]
• Target-Kategorie: CX3CR1,HMG Family,Keap1-Nrf2,NF-kappaB,NOD-like Receptor (NLR),PCSK9

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies